Sellas Stock 346% Year Near Final REGAL Deaths Ahead
Sellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
There are countless ways to make additional income. Find the best methods that suit your skills and schedule to enhance your earnings.
17,258 articlesSellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
Israel confirms its first strike on the Dimona nuclear research site as tensions with Iran escalate, pushing markets ...
Intuitive Machines stock popped today as analysts weigh backlog, milestones, and funding signals. This article breaks...
The Philippines moved to shield households from rising energy costs after the Middle East conflict intensified, decla...
Sarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
Exelon is tapping into accelerating AI data-center demand in Illinois, with Citi signaling upside and a $58 target by...
DeCaro Auctions unveils a broadened leadership slate as it targets international expansion of its luxury real estate ...
Bitcoin briefly climbs above $81,000 as on-chain profits hit a cycle high, prompting traders to weigh the risk of a s...
As the AI rally fans the markets, the boom looks like dot-com. Yet Bitcoin bulls point to a tangible edge—scarcity an...
Intel has surged 116% in the past month as AI demand strengthens data-center demand and early talks of a potential Ap...
A Qatar-linked LNG carrier crossed Hormuz, the first export through the strait since the war intensified. The move co...
Canadian traders face a fast-moving market in May 2026 as platforms race to lower costs and boost real-time data. Thi...